Analyst Ratings for Humana (HUM)
HUM Rating Summary
HUM Price Target Summary
- Highest: $102.00 (Wedbush)
- Lowest: $62.00 (Goldman Sachs)
- Average: $89.30
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$89.30 (+13.1%)
Avg. $ Target:
$89.30 (+13.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/6/2013 | JPMorgan | Upgrade | Overweight (Neutral) |
91.00 (88.00) |
73.93 | 78.93 | 6.76% | Details |
| 4/5/2013 | UBS | New Coverage | Neutral (N/A) |
84.00 (N/A) |
79.60 | 78.93 | -0.84% | Details |
| 3/22/2013 | Susquehanna | Downgrade | Neutral (Positive) |
N/A (N/A) |
68.36 | 78.93 | 15.46% | Details |
| 1/4/2013 | Barclays | New Coverage | Overweight (N/A) |
87.00 (N/A) |
66.25 | 78.93 | 19.14% | Details |
| 11/7/2012 | Goldman Sachs | Downgrade | Sell (Neutral) |
62.00 (77.00) |
76.16 | 78.93 | 3.64% | Details |
| 11/7/2012 | BofA/Merrill Lynch | Downgrade | Neutral (Buy) |
N/A (N/A) |
76.16 | 78.93 | 3.64% | Details |
| 9/4/2012 | Leerink Swann | Upgrade | Outperform (Market Perform) |
92.00 (74.00) |
70.08 | 78.93 | 12.63% | Details |
| 8/30/2012 | Credit Suisse | Downgrade | Neutral (Outperform) |
N/A (N/A) |
70.73 | 78.93 | 11.59% | Details |
| 6/20/2012 | Cantor Fitzgerald | New Coverage | Buy (N/A) |
95.00 (N/A) |
79.32 | 78.93 | -0.49% | Details |
| 5/22/2012 | Wells Fargo | Upgrade | Outperform (N/A) |
96.00 (N/A) |
75.75 | 78.93 | 4.2% | Details |
| 2/21/2012 | Monness, Crespi, Hardt | New Coverage | Neutral (N/A) |
N/A (N/A) |
88.61 | 78.93 | -10.92% | Details |
| 10/12/2011 | Oppenheimer » Updated 9/5/2012 |
Upgrade | Outperform (N/A) |
83.00 (N/A) |
71.81 | 78.93 | 9.92% | Details |
| 3/18/2011 | Argus | Upgrade | Buy (N/A) |
N/A (N/A) |
64.12 | 78.93 | 23.1% | Details |
| 2/28/2011 | Stifel Nicolaus | Upgrade | Buy (N/A) |
N/A (N/A) |
62.60 | 78.93 | 26.09% | Details |
| 2/28/2011 | Jefferies » Updated 4/2/2013 |
Upgrade | Buy (N/A) |
101.00 (93.00) |
62.60 | 78.93 | 26.09% | Details |
